Effects of selective COX-2 and 5-LOX inhibition on prostaglandin and leukotriene synthesis in ductal pancreatic cancer in Syrian hamster

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 2, 2005, Pages 89-97

  Gregor, J I ^a   Kilian, M ^a   Heukamp, I ^b   Kiewert, C ^a   Kristiansen, G ^c   Schimke, I ^d   Walz, M K ^e   Jacobi, C A ^a   Wenger, F A ^e  

^a Visceral   (Germany)

^b Clinic of Internal Medicine   (Germany)

^c Institute of Pathology   (Germany)

^d HUMBOLDT UNIVERSITY   (Germany)

^e KLINIKEN ESSEN MITTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIS(2 OXOPROPYL)NITROSAMINE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; LEUKOTRIENE; LIPOXYGENASE INHIBITOR; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; ZILEUTON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HAMSTER; LIVER; LIVER METASTASIS; MALE; NONHUMAN; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; STATISTICAL SIGNIFICANCE;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CARCINOMA, PANCREATIC DUCTAL; CRICETINAE; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DRUG THERAPY, COMBINATION; HYDROXYUREA; LEUKOTRIENES; LIPOXYGENASE INHIBITORS; LIVER; LIVER NEOPLASMS; PANCREAS; PANCREATIC NEOPLASMS; PROSTAGLANDINS; PROSTAGLANDINS F; PYRAZOLES; SULFONAMIDES;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 22444437119     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.04.016     Document Type: Article

References (47)

1. F.A. Wenger, F. Peter, and J. Zieren Prognosis factors in carcinoma of the head of the pancreas Dig. Surg. 17 2000 29 35
2. A.L. Warshaw, and C. Fernandez-del Castillo Pancreatic carcinoma N. Engl. J. Med. 326 1992 455 465
3. K. Amikura, and M. Kobari The time of occurrence of liver metastasis in carcinoma of the pancreas Int. J. Pancreatol. 17 1996 139 146
4. R.A. Karmali Eicosanoids in neoplasia Prev. Med. 16 4 1987 493 502
5. F. Marks, G. Fürstenberger, and K. Müller-Decker Metabolic targets of cancer chemoprevention: interruption of tumour development by inhibitors of arachidonic acid metabolism A. Senn A. Costa A. Jordan Cemoprevention of Cancer 1999 Springer Berlin/Heidelberg
6. M. Tsujii, and R.N. DuBois Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxidase synthase 2 Cell 83 1995 493 501
7. O.N. Tucker, A.J. Dannenberg, E.K. Yang, F. Zhang, L. Teng, J.M. Daly, R.A. Soslow, J. Masferrer, B. Woerner, A.T. Koki, and T.J. Fahey Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer Cancer Res. 59 1999 987 990
8. D. Hwang, D. Scollard, J. Byrne, and E. Levine Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer J. Natl. Cancer Inst. 90 6 1998 455 460
9. F.G. Ondrey Arachidonic acid metabolism: a primer for head and neck surgeons Head Neck 1998 334 349
10. G. Ara, and B.A. Teicher Cyclooxygenase and lipoxygenase inhibitors in cancer therapy Prostglandins Leukot. Essent. Fatty Acids 54 1996 3 16
11. P.K. Lala, and M.N. Saarloos Prostaglandins and the host immune system: application of prostaglandin inhibitors for cancer immunotherapy J.E. Harris D.P. Braun K.M. Anderson Prostaglandin Inhibitors in Tumour Immunology and Immunotherapy 1994 CRC Press Boca Raton
12. T.L. Mc Lemore, W.C. Hubbard, and C.L. Litterst Profiles of prostaglandin biosynthesis in normal lung and tumour tissue from lung cancer patients Cancer Res. 48 1988 3140 3147
13. C.E. Myers, and J. Ghosh Lipoxygenase inhibition in prostate cancer Eur. Urol. 35 1999 395 398
14. B. Damtew, and P.J. Spagnuolo Tumour cell-endothelial cell interactions: evidence for roles for lipoxygenase products of arachidonic acid in metastasis Prostglandins Leukot. Essent. Fatty Acids 56 4 1997 295 300
15. UKCCCR-Guidelines for the welfare of animals in experimental neoplasia. Cancer and Metastasis Reviews (1989) pp. 82-88.
16. New York Academy of Sciences Ad Hoc Committee on Animal Research. Interdisciplinary principles and guidelines for the use of animals in research, marketing and education.
17. F.A. Wenger, C.A. Jacobi, and M. Kilian Does dietary alpha-linolenic acid promote liver metastasis of pancreatic carcinoma initiated by BOP in Syrian hamsters? Ann. Nutr. Metabol. 43 1999 121 126
18. F.A. Wenger, M. Kilian, and C.A. Jacobi Does alpha-linolenic acid in combination with linoleic acid influence liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters? Prostaglandins Leukot. Essent. Fatty Acids 62 2000 329 334
19. M. Meijers, A. van Garderen-Hoetmer, and C.B. Lamers Role of cholecystokinin in the development of BOP-induced pancreatic lesions in hamsters Carcinogenesis 11 1990 2223 2226
20. N.S. Buttar, K.K. Wang, O. Leontovich, J.Y. Westcott, R.J. Pacifico, M.A. Anderson, K.K. Krishnadath, L.S. Lutzke, and L.J. Burgart Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus Gastroenterology 122 4 2002 1101 1112
21. W. Dempke, C. Rie, A. Grothey, and H.J. Schmoll Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol. 127 7 2001 411 417
22. W.S. Chen, S.J. Wie, J.M. Liu, M. Hsiao, J. Kou-Lin, and W.K. Yang Tumour invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac Int. J. Cancer 91 6 2001 894 899
23. K.C. Zimmermann, M. Sarbia, A.A. Weber, F. Borchard, H.E. Gabbert, and K. Schror Cyclooxygenase-2 expression in human esophageal carcinoma Cancer Res. 59 1 1999 198 204
24. F.A. Attiga, P.M. Fernandez, A.T. Weeraratna, M.J. Manyak, and S.R. Paterno Inhibitors of prostaglandin synthesis inhibit human prostate tumour cell invasiveness and reduce the release of matrix metalloproteinases Cancer Res. 60 16 2000 4629 4637
25. K. Uefuji, T. Ichikura, H. Mochizuki, and N. Shinomiya Expression of cyclooxygenase-2 protein in gastric adenocarcinoma J. Surg. Oncol. 69 1998 168 172
26. R. Natarajan, and J. Nadler Role of lipoxygenases in breast cancer Frontiers Biosci. 3 1998 e81 e88
27. M.P. Pour, R.G. Runge, D. Birt, R. Gingell, T. Lawson, D. Nagel, L. Wallcave, and S.Z. Salmasi Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease Cancer 47 1981 1573 1587
28. H.M. Schuller, L. Zhang, D.L. Weddle, A. Castonguay, K. Walker, and M.S. Miller The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK J. Cancer Res. Clin. Oncol. 128 10 2002 525 532
29. F. Furukawa, A. Nishikawa, I.S. Lee, K. Kanki, T. Umemura, K. Okazaki, T. Kawamori, K. Wakabayashi, and M. Hirose A cyclooxygenase-2-inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine- induced pancreatic carcinogenesis in hamsters Int. J. Cancer 104 3 2003 269 273
30. M. Kilian, I. Mautsch, C. Braumann, I. Schimke, H. Guski, C.A. Jacobi, and F.A. Wenger Effects of taurolidine and octreotide on tumor growth and lipid peroxidation after staging-laparoscopy in ductal pancreatic cancer Prostaglandins Leukot. Essent. Fatty Acids 69 4 2003 261 267
31. M. Kilian, I. Mautsch, J.I. Gregor, D. Heinicken, C.A. Jacobi, I. Schimke, H. Guski, J.M. Müller, and F.A. Wenger Influence of conjugated and conventional linoleic acid on tumor growth and lipid peroxidation in pancreatic adenocarcinoma in hamster Prostaglandins Leukot. Essent. Fatty Acids 69 1 2003 67 72
32. F.A. Attiga, M. Fernandez, A.T. Weerararatna, M.J. Manyak, and S.R. Paterno Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases Cancer Res. 60 2000 4629 4637
33. K.M. Leahy, R.L. Ornberg, Y. Wang, B.S. Zweifel, A.T. Koki, and J.L. Masferrer Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo Cancer Res. 62 2002 625 631
34. I. Avis, S.H. Hong, A. Martinez, T. Moody, Y.H. Choi, J. Trepel, R. Das, M. Jett, and J.L. Mulshine Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions FASEB J. 15 2001 2007 2009
35. A. Kirschenbaum, X. Liu, S. Yao, and A.C. Levine The role of cyclooxygenase-2 in prostate cancer Urology 58 2 Suppl 1 2001 127 131
36. M. Tsujii, S. Kawano, S. Tsuji, H. Sawaoka, M. Hori, and R.N. DuBois Cyclooxygenase regulates angiogenesis induced by colon cancer cells Cell 93 29 1998 705 716
37. N. Nathoo, G.H. Barnett, and M. Golubic The eicosanoid cascade: possible role in gliomas and meningiomas J. Clin. Pathol. 57 1 2004 6 13
38. W.G. Tong, X.Z. Ding, R.C. Witt, and T.E. Adrian Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway Molecular Cancer Therapeutics 1 2002 929 935
39. P.P.H. Lee, and M.M. Ip Regulation of proliferation of rat mammary tumour cells by inhibitors of cyclooxygenase and lipoxygenase Prostglandins. Leukot. Essent. Fatty Acids 45 1992 21 31
40. C. Cordon-Cardo, and C. Prives At the crossroads of inflammation and tumourigenesis J. Exp. Med. 190 1999 1367 1370
41. J.D. Hudson, M.A. Shoaibi, R. Maestro, A. Carnero, G.J. Hannon, and D.H. Beach A proinflammatory cytokine inhibits p53 tumour suppressor activity J. Exp. Med. 190 1999 1375 1382
42. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
43. C.M. Baich, P.A. Doghert, G.A. Cloud, and A.B. Tilden Prostaglandin-E2-mediated suppression of cellular immunity in colon cancer patients Surgery 95 1984 71 77
44. A.B. Tilden, and C.M. Balch Indomethacin enhancement of immunocompetence in melanoma patients Surgery 90 1981 77 84
45. K.D. Grinwich, and O.J. Plescia Tumour-mediated immunosuppression: prevention by inhibitors of prostaglandin synthesis Prostaglandins 14 1977 1175 1183
46. S.W. Russell, and J.L. Pace Both the kind and magnitude of stimulus are important in overcoming the negative regulation of macrophage activation by PGE2 J. Leukot. Biol. 35 1984 291 301
47. S.L. Kunkel, R.C. Wiggins, S.W. Chensue, and J. Larrick Regulation of macrophage tumour necrosis factor production by prostaglandin E2 Biochem. Biophys. Res. Commun. 137 1986 404 410